Bayer to shed Material Science unit via IPO
This article was originally published in Scrip
Executive Summary
Bayer is spinning off its Material Science unit and will float it on the stock markets as a separate company so it can focus entirely on its two Life Science businesses – Health Care and Crop Science. The decision follows recent similar moves by its pharma peers to shed non-core businesses.